| Generic name | Asparaginase Erwinia chrysanthemi |
| Pronunciation | as-PAYR-uh-jih-NAYS er-WIH-nee-uh krih-SAN-theh-my |
| Brand name(s), other common name(s) | ErwinazeTM |
| Drug type | Enzyme that prevents cancer cells from surviving |
| How the drug is given | Intramuscular (IM) injection |
Indications and Usage
Asparaginase Erwinia chrysanthemi is an asparagine specific enzyme indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.
Side effects needing medical attention
Serious allergic reactions (tightness in throat, abnormal swelling/redness or difficulty breathing), some of which may be life-threatening; inflammation of the pancreatitis (stomach pain); abnormal blood clotting (may have headache, pain in leg, arm, or chest); unusual bleeding; liver problems; nausea, vomiting, and abnormal blood sugar levels (may be thirsty or frequently urinate).
For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.